Investor Relations

Press Releases

ASX Announcements Releases
  REVA Symposium Showcases Clinical Data
May 18, 2017
PDF 5.0 MB Add to Briefcase
  REVA Announces Positive 12-Month Clinical Results
May 17, 2017
PDF 3.3 MB Add to Briefcase
  Quarterly Report on Form 10-Q
May 10, 2017
PDF 503.3 KB Add to Briefcase
  Issuance of Convertible Notes and Options
May 5, 2017
PDF 290.7 KB Add to Briefcase
  Amendment No. 1 to Form 10-K
May 2, 2017
PDF 598.1 KB Add to Briefcase
  Appendix 4C - quarterly
Apr 28, 2017
PDF 260.6 KB Add to Briefcase
  Notice of Briefing Call
Apr 28, 2017
PDF 135.3 KB Add to Briefcase
  Enrollment Initiated in Expanded FANTOM II Trial
Apr 26, 2017
PDF 151.2 KB Add to Briefcase
  Prospectus for Offering of Convertible Notes and Options
Apr 24, 2017
PDF 864.5 KB Add to Briefcase
  Convertible Note Financing Arranged
Apr 24, 2017
PDF 198.2 KB Add to Briefcase
  Announcement of buy-back - Appendix 3C
Apr 24, 2017
PDF 149.6 KB Add to Briefcase
  REVA to Present at EuroPCR 2017
Apr 12, 2017
PDF 151.2 KB Add to Briefcase
  REVA Receives CE Mark for Fantom
Apr 4, 2017
PDF 149.5 KB Add to Briefcase
  Appendix 4G
Mar 30, 2017
PDF 149.1 KB Add to Briefcase
  Appendix 3B
Mar 27, 2017
PDF 297.5 KB Add to Briefcase
  FANTOM II Trial to be Expanded to More Complex Cases
Mar 24, 2017
PDF 151.4 KB Add to Briefcase
  Appendix 4C - quarterly (revised)
Mar 17, 2017
PDF 254.7 KB Add to Briefcase
  Notice of Briefing Call
Mar 9, 2017
PDF 134.6 KB Add to Briefcase
  Form S-8 Filed with SEC
Mar 1, 2017
PDF 211.2 KB Add to Briefcase
  Preliminary Final Report and Annual Report on Form 10-K
Feb 28, 2017
PDF 806.6 KB Add to Briefcase
Showing 1-20 of 352 Page: 1 2 3 4 5 ... 18  Next 20
Add to Briefcase = add release to Briefcase